Atorvastatin (Indonesian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Atorvastatin" in Indonesian language version.

refsWebsite

Global rank Indonesian rank

28nih.gov

4^th place

13^th place

20doi.org

2^nd place

4^th place

2worldcat.org

5^th place

7^th place

1aspetjournals.org

6,663^rd place

9,643^rd place

1drugs.com

399^th place

480^th place

1books.google.com

3^rd place

6^th place

1google.com

163^rd place

114^th place

1elsevier.com

610^th place

597^th place

1ahajournals.org

3,608^th place

4,055^th place

1ijcem.com

low place

1web.archive.org

1^st place

1fda.gov

447^th place

792^nd place

1webmd.com

1,169^th place

842^nd place

1mayoclinic.org

1,610^th place

1,940^th place

ahajournals.org

Nawrocki, James W.; Weiss, Stuart R.; Davidson, Michael H.; Sprecher, Dennis L.; Schwartz, Sherwyn L.; Lupien, Paul-J.; Jones, Peter H.; Haber, Harry E.; Black, Donald M. (1995-05). "Reduction of LDL Cholesterol by 25% to 60% in Patients With Primary Hypercholesterolemia by Atorvastatin, a New HMG-CoA Reductase Inhibitor". Arteriosclerosis, Thrombosis, and Vascular Biology (dalam bahasa Inggris). 15 (5): 678–682. doi:10.1161/01.ATV.15.5.678. ISSN 1079-5642.

aspetjournals.org

dmd.aspetjournals.org

Niessen, Juliane; Jedlitschky, Gabriele; Grube, Markus; Bien, Sandra; Schwertz, Hansjörg; Ohtsuki, Sumio; Kawakami, Hirotaka; Kamiie, Junichi; Oswald, Stefan (2009-05). "Human Platelets Express Organic Anion-Transporting Peptide 2B1, an Uptake Transporter for Atorvastatin". Drug Metabolism and Disposition (dalam bahasa Inggris). 37 (5): 1129–1137. doi:10.1124/dmd.108.024570. ISSN 0090-9556.

books.google.com

Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. hlm. 473. ISBN 9783527607495.

doi.org

Niessen, Juliane; Jedlitschky, Gabriele; Grube, Markus; Bien, Sandra; Schwertz, Hansjörg; Ohtsuki, Sumio; Kawakami, Hirotaka; Kamiie, Junichi; Oswald, Stefan (2009-05). "Human Platelets Express Organic Anion-Transporting Peptide 2B1, an Uptake Transporter for Atorvastatin". Drug Metabolism and Disposition (dalam bahasa Inggris). 37 (5): 1129–1137. doi:10.1124/dmd.108.024570. ISSN 0090-9556.
McCrindle, Brian W; Ose, Leiv; Marais, A.David (2003-07). "Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial". The Journal of Pediatrics (dalam bahasa Inggris). 143 (1): 74–80. doi:10.1016/S0022-3476(03)00186-0.
Nawrocki, James W.; Weiss, Stuart R.; Davidson, Michael H.; Sprecher, Dennis L.; Schwartz, Sherwyn L.; Lupien, Paul-J.; Jones, Peter H.; Haber, Harry E.; Black, Donald M. (1995-05). "Reduction of LDL Cholesterol by 25% to 60% in Patients With Primary Hypercholesterolemia by Atorvastatin, a New HMG-CoA Reductase Inhibitor". Arteriosclerosis, Thrombosis, and Vascular Biology (dalam bahasa Inggris). 15 (5): 678–682. doi:10.1161/01.ATV.15.5.678. ISSN 1079-5642.
Rosa GM, Carbone F, Parodi A, Massimelli EA, Brunelli C, Mach F, et al. (May 2014). "Update on the efficacy of statin treatment in acute coronary syndromes". European Journal of Clinical Investigation. 44 (5): 501–15. doi:10.1111/eci.12255. PMID 24601937.
Furie KL (July 2012). "High-dose statins should only be used in atherosclerotic strokes". Stroke. 43 (7): 1994–5. doi:10.1161/STROKEAHA.111.633339. PMID 22581818.
Su X, Zhang L, Lv J, Wang J, Hou W, Xie X, Zhang H (June 2016). "Effect of Statins on Kidney Disease Outcomes: A Systematic Review and Meta-analysis". American Journal of Kidney Diseases. 67 (6): 881–92. doi:10.1053/j.ajkd.2016.01.016. PMID 26905361.
Xiong B, Nie D, Cao Y, Zou Y, Yao Y, Qian J, et al. (November 2017). "Preoperative Statin Treatment for the Prevention of Acute Kidney Injury in Patients Undergoing Cardiac Surgery: A Meta-Analysis of Randomised Controlled Trials". Heart, Lung & Circulation. 26 (11): 1200–1207. doi:10.1016/j.hlc.2016.11.024. PMID 28242291.
Zhou X, Dai J, Xu X, Wang Z, Xu H, Chen J, et al. (April 2019). "Comparative Efficacy of Statins for Prevention of Contrast-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease: A Network Meta-Analysis". Angiology. 70 (4): 305–316. doi:10.1177/0003319718801246. PMID 30261736.
Ma WQ, Zhao Y, Wang Y, Han XQ, Zhu Y, Liu NF (June 2018). "Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials" (PDF). International Urology and Nephrology. 50 (6): 1085–1095. doi:10.1007/s11255-018-1814-0. PMID 29404930.
Cho A, Lee YK, Sohn SY (March 2020). "Beneficial effect of statin on preventing contrast-induced acute kidney injury in patients with renal insufficiency: A meta-analysis". Medicine. 99 (10): e19473. doi:10.1097/MD.0000000000019473. PMID 32150109.
Zhang J, Guo Y, Jin Q, Bian L, Lin P (October 2018). "Meta-analysis of rosuvastatin efficacy in prevention of contrast-induced acute kidney injury". Drug Design, Development and Therapy. 12: 3685–3690. doi:10.2147/DDDT.S178020. PMID 30464400.
Shah RV, Goldfine AB (October 2012). "Statins and risk of new-onset diabetes mellitus". Circulation. 126 (18): e282–4. doi:10.1161/CIRCULATIONAHA.112.122135. PMID 23109518.
Macedo AF, Taylor FC, Casas JP, Adler A, Prieto-Merino D, Ebrahim S (March 2014). "Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis". BMC Medicine. 12: 51. doi:10.1186/1741-7015-12-51. PMC 3998050 . PMID 24655568.
Kashani A, Phillips CO, Foody JM, Wang Y, Mangalmurti S, Ko DT, Krumholz HM (December 2006). "Risks associated with statin therapy: a systematic overview of randomized clinical trials". Circulation. 114 (25): 2788–97. doi:10.1161/CIRCULATIONAHA.106.624890. PMID 17159064.
Newman CB, Palmer G, Silbershatz H, Szarek M (September 2003). "Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patients". American Journal of Cardiology. 92 (6): 670–6. doi:10.1016/S0002-9149(03)00820-8. PMID 12972104.
Kostapanos MS, Liamis GL, Milionis HJ, Elisaf MS (September 2010). "Do statins beneficially or adversely affect glucose homeostasis?". Current Vascular Pharmacology. 8 (5): 612–31. doi:10.2174/157016110792006879. PMID 20507274.
Wolfe D, Kanji S, Yazdi F, Barbeau P, Rice D, Beck A, Butler C, Esmaeilisaraji L, Skidmore B, Moher D, Hutton B (2020). "Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations". PLoS ONE. 15 (4): e0231883. doi:10.1371/journal.pone.0231883. PMC 7164626 . PMID 32302358.
Liberale L, Carbone F, Montecucco F, Sahebkar A (May 2020). "Statins reduce vascular inflammation in atherogenesis: A review of underlying molecular mechanisms". International Journal of Biochemistry & Cell Biology. 122: 105735. doi:10.1016/j.biocel.2020.105735. PMID 32126319.
Canestaro WJ, Austin MA, Thummel KE (November 2014). "Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review". Genet Med. 16 (11): 810–9. doi:10.1038/gim.2014.41. PMC 4676271 . PMID 24810685.
Thompson JF, Man M, Johnson KJ, Wood LS, Lira ME, Lloyd DB, et al. (2005). "An association study of 43 SNPs in 16 candidate genes with atorvastatin response". Pharmacogenomics Journal. 5 (6): 352–8. doi:10.1038/sj.tpj.6500328. PMID 16103896.

drugs.com

"Atorvastatin Calcium Monograph for Professionals". Drugs.com. AHFS. Diakses tanggal 23 December 2018.

elsevier.com

linkinghub.elsevier.com

McCrindle, Brian W; Ose, Leiv; Marais, A.David (2003-07). "Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial". The Journal of Pediatrics (dalam bahasa Inggris). 143 (1): 74–80. doi:10.1016/S0022-3476(03)00186-0.

fda.gov

"FDA Expands Advice on Statin Risks". U.S. Food and Drug Administration (FDA). 31 January 2014. Diarsipkan dari versi asli tanggal 18 November 2015. Diakses tanggal 24 November 2015.

google.com

Hitchings A, Lonsdale D, Burrage D, Baker E (2014). The Top 100 Drugs e-book: Clinical Pharmacology and Practical Prescribing. Elsevier Health Sciences. hlm. 197. ISBN 978-0-7020-5515-7.

ijcem.com

Ma WQ, Zhao Y, Wang Y, Han XQ, Zhu Y, Liu NF (June 2018). "Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials" (PDF). International Urology and Nephrology. 50 (6): 1085–1095. doi:10.1007/s11255-018-1814-0. PMID 29404930.

mayoclinic.org

Mayo Clinic Staff. "Statin Side Effects: Weigh the Risks and Benefits". The Mayo Clinic. Diakses tanggal 19 April 2014.

nih.gov

ncbi.nlm.nih.gov

Rg, Bakker-Arkema; Mh, Davidson; Rj, Goldstein; J, Davignon; Jl, Isaacsohn; Sr, Weiss; Lm, Keilson; Wv, Brown; Vt, Miller (1996-01-10). "Efficacy and Safety of a New HMG-CoA Reductase Inhibitor, Atorvastatin, in Patients With Hypertriglyceridemia". JAMA (dalam bahasa Inggris). PMID 8531308. Diakses tanggal 2020-05-25.
K, Ozaki; T, Kubo; R, Imaki; H, Shinagawa; H, Fukaya; K, Ohtaki; S, Ozaki; T, Izumi; Y, Aizawa (2006 Aug). "The Anti-Atherosclerotic Effects of Lipid Lowering With Atorvastatin in Patients With Hypercholesterolemia". Journal of atherosclerosis and thrombosis (dalam bahasa Inggris). PMID 16908955. Diakses tanggal 2020-05-25.
Bw, McCrindle; L, Ose; Ad, Marais (2003 Jul). "Efficacy and Safety of Atorvastatin in Children and Adolescents With Familial Hypercholesterolemia or Severe Hyperlipidemia: A Multicenter, Randomized, Placebo-Controlled Trial". The Journal of pediatrics (dalam bahasa Inggris). PMID 12915827. Diakses tanggal 2020-05-25.
Bw, McCrindle; L, Ose; Ad, Marais (2003 Jul). "Efficacy and Safety of Atorvastatin in Children and Adolescents With Familial Hypercholesterolemia or Severe Hyperlipidemia: A Multicenter, Randomized, Placebo-Controlled Trial". The Journal of pediatrics (dalam bahasa Inggris). PMID 12915827. Diakses tanggal 2020-05-25.
Ad, Marais; Jc, Firth; Me, Bateman; P, Byrnes; C, Martens; J, Mountney (1997 Aug). "Atorvastatin: An Effective Lipid-Modifying Agent in Familial Hypercholesterolemia". Arteriosclerosis, thrombosis, and vascular biology (dalam bahasa Inggris). PMID 9301631. Diakses tanggal 2020-05-25.
Rosa GM, Carbone F, Parodi A, Massimelli EA, Brunelli C, Mach F, et al. (May 2014). "Update on the efficacy of statin treatment in acute coronary syndromes". European Journal of Clinical Investigation. 44 (5): 501–15. doi:10.1111/eci.12255. PMID 24601937.
Furie KL (July 2012). "High-dose statins should only be used in atherosclerotic strokes". Stroke. 43 (7): 1994–5. doi:10.1161/STROKEAHA.111.633339. PMID 22581818.
Su X, Zhang L, Lv J, Wang J, Hou W, Xie X, Zhang H (June 2016). "Effect of Statins on Kidney Disease Outcomes: A Systematic Review and Meta-analysis". American Journal of Kidney Diseases. 67 (6): 881–92. doi:10.1053/j.ajkd.2016.01.016. PMID 26905361.
Xiong B, Nie D, Cao Y, Zou Y, Yao Y, Qian J, et al. (November 2017). "Preoperative Statin Treatment for the Prevention of Acute Kidney Injury in Patients Undergoing Cardiac Surgery: A Meta-Analysis of Randomised Controlled Trials". Heart, Lung & Circulation. 26 (11): 1200–1207. doi:10.1016/j.hlc.2016.11.024. PMID 28242291.
Zhou X, Dai J, Xu X, Wang Z, Xu H, Chen J, et al. (April 2019). "Comparative Efficacy of Statins for Prevention of Contrast-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease: A Network Meta-Analysis". Angiology. 70 (4): 305–316. doi:10.1177/0003319718801246. PMID 30261736.
Ma WQ, Zhao Y, Wang Y, Han XQ, Zhu Y, Liu NF (June 2018). "Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials" (PDF). International Urology and Nephrology. 50 (6): 1085–1095. doi:10.1007/s11255-018-1814-0. PMID 29404930.
Cho A, Lee YK, Sohn SY (March 2020). "Beneficial effect of statin on preventing contrast-induced acute kidney injury in patients with renal insufficiency: A meta-analysis". Medicine. 99 (10): e19473. doi:10.1097/MD.0000000000019473. PMID 32150109.
Zhang J, Guo Y, Jin Q, Bian L, Lin P (October 2018). "Meta-analysis of rosuvastatin efficacy in prevention of contrast-induced acute kidney injury". Drug Design, Development and Therapy. 12: 3685–3690. doi:10.2147/DDDT.S178020. PMID 30464400.
Shah RV, Goldfine AB (October 2012). "Statins and risk of new-onset diabetes mellitus". Circulation. 126 (18): e282–4. doi:10.1161/CIRCULATIONAHA.112.122135. PMID 23109518.
Macedo AF, Taylor FC, Casas JP, Adler A, Prieto-Merino D, Ebrahim S (March 2014). "Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis". BMC Medicine. 12: 51. doi:10.1186/1741-7015-12-51. PMC 3998050 . PMID 24655568.
Kashani A, Phillips CO, Foody JM, Wang Y, Mangalmurti S, Ko DT, Krumholz HM (December 2006). "Risks associated with statin therapy: a systematic overview of randomized clinical trials". Circulation. 114 (25): 2788–97. doi:10.1161/CIRCULATIONAHA.106.624890. PMID 17159064.
Newman CB, Palmer G, Silbershatz H, Szarek M (September 2003). "Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patients". American Journal of Cardiology. 92 (6): 670–6. doi:10.1016/S0002-9149(03)00820-8. PMID 12972104.
Kostapanos MS, Liamis GL, Milionis HJ, Elisaf MS (September 2010). "Do statins beneficially or adversely affect glucose homeostasis?". Current Vascular Pharmacology. 8 (5): 612–31. doi:10.2174/157016110792006879. PMID 20507274.
Wolfe D, Kanji S, Yazdi F, Barbeau P, Rice D, Beck A, Butler C, Esmaeilisaraji L, Skidmore B, Moher D, Hutton B (2020). "Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations". PLoS ONE. 15 (4): e0231883. doi:10.1371/journal.pone.0231883. PMC 7164626 . PMID 32302358.
Liberale L, Carbone F, Montecucco F, Sahebkar A (May 2020). "Statins reduce vascular inflammation in atherogenesis: A review of underlying molecular mechanisms". International Journal of Biochemistry & Cell Biology. 122: 105735. doi:10.1016/j.biocel.2020.105735. PMID 32126319.
Canestaro WJ, Austin MA, Thummel KE (November 2014). "Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review". Genet Med. 16 (11): 810–9. doi:10.1038/gim.2014.41. PMC 4676271 . PMID 24810685.
Thompson JF, Man M, Johnson KJ, Wood LS, Lira ME, Lloyd DB, et al. (2005). "An association study of 43 SNPs in 16 candidate genes with atorvastatin response". Pharmacogenomics Journal. 5 (6): 352–8. doi:10.1038/sj.tpj.6500328. PMID 16103896.

pubmed.ncbi.nlm.nih.gov

Rg, Bakker-Arkema; Mh, Davidson; Rj, Goldstein; J, Davignon; Jl, Isaacsohn; Sr, Weiss; Lm, Keilson; Wv, Brown; Vt, Miller (1996-01-10). "Efficacy and Safety of a New HMG-CoA Reductase Inhibitor, Atorvastatin, in Patients With Hypertriglyceridemia". JAMA (dalam bahasa Inggris). PMID 8531308. Diakses tanggal 2020-05-25.
K, Ozaki; T, Kubo; R, Imaki; H, Shinagawa; H, Fukaya; K, Ohtaki; S, Ozaki; T, Izumi; Y, Aizawa (2006 Aug). "The Anti-Atherosclerotic Effects of Lipid Lowering With Atorvastatin in Patients With Hypercholesterolemia". Journal of atherosclerosis and thrombosis (dalam bahasa Inggris). PMID 16908955. Diakses tanggal 2020-05-25.
Bw, McCrindle; L, Ose; Ad, Marais (2003 Jul). "Efficacy and Safety of Atorvastatin in Children and Adolescents With Familial Hypercholesterolemia or Severe Hyperlipidemia: A Multicenter, Randomized, Placebo-Controlled Trial". The Journal of pediatrics (dalam bahasa Inggris). PMID 12915827. Diakses tanggal 2020-05-25.
Bw, McCrindle; L, Ose; Ad, Marais (2003 Jul). "Efficacy and Safety of Atorvastatin in Children and Adolescents With Familial Hypercholesterolemia or Severe Hyperlipidemia: A Multicenter, Randomized, Placebo-Controlled Trial". The Journal of pediatrics (dalam bahasa Inggris). PMID 12915827. Diakses tanggal 2020-05-25.
Ad, Marais; Jc, Firth; Me, Bateman; P, Byrnes; C, Martens; J, Mountney (1997 Aug). "Atorvastatin: An Effective Lipid-Modifying Agent in Familial Hypercholesterolemia". Arteriosclerosis, thrombosis, and vascular biology (dalam bahasa Inggris). PMID 9301631. Diakses tanggal 2020-05-25.

toxnet.nlm.nih.gov

"TOXNET". toxnet.nlm.nih.gov. U.S. National Library of Medicine. Diakses tanggal 29 May 2018.

web.archive.org

"FDA Expands Advice on Statin Risks". U.S. Food and Drug Administration (FDA). 31 January 2014. Diarsipkan dari versi asli tanggal 18 November 2015. Diakses tanggal 24 November 2015.

webmd.com

Salynn, Boyles (9 January 2012). "Statins May Raise Diabetes Risk in Older Women: Study: Middle-Aged, Older Statin Users Had More Type 2 Diabetes". WebMD Health News. Diakses tanggal 24 November 2015.

worldcat.org

Niessen, Juliane; Jedlitschky, Gabriele; Grube, Markus; Bien, Sandra; Schwertz, Hansjörg; Ohtsuki, Sumio; Kawakami, Hirotaka; Kamiie, Junichi; Oswald, Stefan (2009-05). "Human Platelets Express Organic Anion-Transporting Peptide 2B1, an Uptake Transporter for Atorvastatin". Drug Metabolism and Disposition (dalam bahasa Inggris). 37 (5): 1129–1137. doi:10.1124/dmd.108.024570. ISSN 0090-9556.
Nawrocki, James W.; Weiss, Stuart R.; Davidson, Michael H.; Sprecher, Dennis L.; Schwartz, Sherwyn L.; Lupien, Paul-J.; Jones, Peter H.; Haber, Harry E.; Black, Donald M. (1995-05). "Reduction of LDL Cholesterol by 25% to 60% in Patients With Primary Hypercholesterolemia by Atorvastatin, a New HMG-CoA Reductase Inhibitor". Arteriosclerosis, Thrombosis, and Vascular Biology (dalam bahasa Inggris). 15 (5): 678–682. doi:10.1161/01.ATV.15.5.678. ISSN 1079-5642.